Access to Medicines and TRIPS Compliance in India and Brazil

Research output: Contribution to journalArticleScientificpeer-review

Abstract

This paper analyses access to medicines in India and Brazil after the entry into force of the TRIPS Agreements, covering the different response of both countries as to its implementation. Such International Treaty has introduced deep innovations in the international framework for patents that may create a barrier to the access of more affordable medicines. The paper covers emblematic case law from both countries and concludes with an assessment of the different implementation strategies.
Original languageEnglish
Pages (from-to)790-801
Number of pages12
JournalEuropean Intellectual Property Review: A Monthly Review: A Journal concerning the Management of Technology, Copyrights and Trade Names
Volume36
Issue number12
Publication statusPublished - 2014
Externally publishedYes

    Fingerprint

Keywords

  • Access to medicines; Brazil; Comparative law; Compulsory licensing; India; Pharmaceuticals; TRIPs

Cite this